DePuy Synthes

Company

Related News

J&J Explores $20B+ Sale of DePuy Synthes as Unit Acquires Spine Implant Maker

Jul 16, 2026

Johnson & Johnson is preparing a potential sale of its DePuy Synthes orthopedics unit, valued at over $20 billion, with private equity firms showing interest. Concurrently, the unit has acquired spine implant maker Expanding Innovations to bolster its technology portfolio.

Johnson & Johnson Plans $1B Cell Therapy Plant, Explores $20B DePuy Synthes Sale

Mar 03, 2026

Johnson & Johnson announced a $1 billion cell therapy manufacturing facility in Pennsylvania while reportedly exploring a sale of its DePuy Synthes orthopedics business for over $20 billion.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT07747831	Powered Impaction and Broaching in Elderly Total Hip Arthroplasty	NOT_YET_RECRUITING	NA